pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
Anti-CD20 monoclonal antibody and the BTK inhibitor
Phase 1 · small molecule · Anti-CD20 Monoclonal Antibody
Anti-CD20 monoclonal antibody and the BTK inhibitor for Anti-CD20 Monoclonal Antibody is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code 2026-50
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Anti-CD20 Monoclonal Antibody
- Status
- active
- Trials
- 1